How cells keep calcium levels balanced

Deciphering Molecular Mechanisms of Calcium Homeostasis

NIH-funded research Albany Medical College · NIH-11192831

Researchers are using a tiny worm model to learn how changes in cellular calcium tied to presenilin may lead to nerve cell damage in people with Alzheimer's.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAlbany Medical College NIH-funded
Lab location1 site (Albany, United States)
Project IDNIH-11192831 on NIH RePORTER

What this research studies

The team uses the microscopic worm C. elegans because it carries a version of the human presenilin protein to examine calcium movement between the endoplasmic reticulum and mitochondria. They modify the worm presenilin gene (SEL-12) and measure mitochondrial calcium, energy use, protein folding, and signs of neuron damage. The work combines genetic manipulations, biological assays, and behavioral tests in worms to identify processes that keep calcium in balance. Results are meant to point to molecular steps that could be targeted in future Alzheimer's therapies.

Who could benefit from this research

Good fit: Although the project uses lab models and does not enroll people, the findings would most directly interest people living with Alzheimer's disease or those with genetic risk for early-onset forms.

Not a fit: People seeking immediate treatments, those with unrelated medical conditions, or patients looking to join a clinical trial will not directly benefit from this lab-based work.

Why it matters

Potential benefit: If successful, this work could reveal molecular targets to prevent calcium-driven neuron damage and help guide development of new treatments for Alzheimer's disease.

How similar studies have performed: Previous lab studies have linked presenilin and calcium dysregulation to neurodegeneration, but translating these basic findings into effective human therapies has not yet been achieved.

Where this research is happening

Albany, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.